EpiCept Provides Update on Clinical and Regulatory Progress with Ceplene(TM) and EpiCept(TM) ...(l controls;and risks associated with our...),Health

Date:1/22/2008

l controls; and risks associated with our ability to protect our intellectual property. These factors and other material risks are more fully discussed in EpiCept's periodic reports, including its reports on Forms 8-K, 10-Q and 10-K and other filings with the U.S. Securities and Exchange Commission. You are urged to carefully review and consider the disclosures found in EpiCept's filings which are available at http://www.sec.gov or at http://www.epicept.com. You are cautioned not to place undue reliance on any forward-looking statements, any of which could turn out to be wrong due to inaccurate assumptions, unknown risks or uncertainties or other risk factors.

EPCT-GEN

*Azixa is a registered trademark of Myriad Genetics, Inc.

'/>"/>

SOURCE EpiCept Corporation Copyright©2008 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4
Related medicine technology :

1. EpiCept Announces Successful Completion of Enrollment for Phase I Trial of EPC2407
2. EpiCept Reports Regulatory Progress on Ceplene(TM)
3. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
4. DuPont Provides Technology for Washington Hospital Centers Emergency Department
5. Idenix Pharmaceuticals Provides Update on Hepatitis C Pipeline at JP Morgan Healthcare Conference
6. ImaRx Provides Update on TUCSON Phase I/II Clinical Trial in Acute Ischemic Stroke
7. Progen Provides Update on Phase 3 Clinical Program for PI-88 in Liver Cancer
8. IDM Pharma Provides Update of Product Pipeline and Announces Plans to Evaluate Strategic Alternatives for the Company
9. NicOx Completes Enrollment in Second Pivotal Phase 3 Study for Naproxcinod and Provides Development Update
10. Radiesse Provides Greater Patient Satisfaction Than Either Juvederm or Perlane as Reported in a 205-Patient Clinical Trial Published in the Journal of Dermatologic Surgery
11. Replidyne Provides Strategic Update